Pharmaceutical Intermediate Canagliflozin/Canagliflozin Hemihydrate CAS 928672-86-0

• Powder: Yes
• Customized: Non-Customized
• Certification: ISO 9001, USP, SGS
• Suitable for: Elderly, Adult
• State: Solid
• Purity: >99%
• Model NO.: FS 928672-86-0
• Storage Condition: Store at Rt
• Colour: White
• Transport Package: Aluminum Foil Bag
• Trademark: FOUSI
• Origin: China
• Production Capacity: 1000kg/Month

Product Description

 

Pharmaceutical Intermediate  Canagliflozin/Canagliflozin heMihydrate CAS 928672-86-0 

Product Description

Kanggligin is a selective type 2 sodium glucose transporter (SGLT-2) inhibitor, which can specifically inhibit the reabsorption of glucose by kidney. Excessive Kanggligin is a selective type 2 sodium glucose transporter (SGLT-2) inhibitor, which can specifically inhibit the reabsorption of glucose by kidney, and cause excessive glucose to be discharged from urine, thus directly reducing blood glucose level.

Product picture

 

 

Product Parameters

 

Product Name	Canagliflozin heMihydrate
MF	2(C24H25FO5S).H2O
EINECS	202-303-5
Related categories	Kangglizine hemihydrate; Medicine inhibitor; API of API; Pharmaceutical intermediates; Intermediate of kaglinide; Chemical raw materials; API; Canagliflozin

 

Application of Canagliflozin heMihydrate:

Kagglinide hemihydrate is an oral C- glycoside sodium-dependent glucose 2 cotransporter (SGLT2) inhibitor originally developed by Mitsubishi International Pharma Co., Ltd. It can block the reabsorption of glucose by the proximal convoluted tubule, so that the filtered glucose can be discharged from urine, thus achieving the purpose of lowering blood sugar..

 

Packaging & Shipping

Company Profile

 

 

FAQ